Scilex Holding Company has paid off the remaining balance of approx. $1,300,000 under the convertible debentures previously issued and sold to YA II PN, in March 2023. Scilex has also voluntarily made an early payment in the aggregate amount of $15,000,000 under the senior secured promissory note issued to Oramed Pharmaceuticals in September 2023.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SCLX:
- Scilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc.
- Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of Such Release and Settlement
- Scilex enters release, settlement agreement with Virpax Pharmaceuticals
- Riding the Biotech Rollercoaster: Scilex’s Stock Volatility Amid Sector Uncertainty
- Scilex Holding Company Announces Closing of $10 Million Bought Deal Offering